Drug intelligence / Profile preview

Fu Tiankang + policresulen + chitosan

Development stage
Unknown
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Topical, Vaginal
01

Overview

Fu Tiankang + policresulen + chitosan is a **combination drug** formulated for topical or local treatment, primarily targeting **gynecological or mucosal infections and inflammation**. - **Fu Tiankang** appears to be a medicinal product related to women's reproductive health, though no direct English-language regulatory or pharmacological profile could be found in available databases. It may be a product from the Chinese traditional medicine domain or a branded gynecological treatment, often indicated for conditions like vaginal or pelvic infections. - **Policresulen** is a synthetic organic acid with strong antiseptic and hemostatic properties, used clinically to treat infections, cervical erosions, and for its ability to promote selective coagulation and removal of pathologically altered tissues while sparing healthy tissue. - **Chitosan** is a natural polysaccharide derived from chitin, widely used for its **biocompatible, anti-inflammatory, wound healing, and antimicrobial properties**. It is frequently included in topical formulations to enhance mucosal healing and protection. Combined, these ingredients are designed to: - Treat or manage **infections**, particularly in gynecological or mucosal contexts. - Promote the healing of mucosal surfaces. - Provide **antimicrobial, hemostatic, and tissue-protective** effects. This formulation is likely used as a **local (topical or vaginal)** application, either as a gel, suppository, or tablet, targeting **vaginal, cervical, or other mucosal infections and lesions**.

Other names
Fu Tiankang combined with policresulen and chitosan
02

Targets

Bacterial cell membrane phospholipids and associated envelope components

Beyond the preview

Go deeper on Fu Tiankang + policresulen + chitosan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fu Tiankang + policresulen + chitosan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call